DAC treatment reduces the methylation level by approximately 15% and increases the transcript and protein levels of MAGEA6 in AML cells, suggesting that promoter methylation modulates the silencing of MAGEA6 expression. This evidence concerns the gene MAGEA6 and acute myeloid leukemia.